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Abstract: Maternal lifestyle is an important factor in the programming of an infant’s epigenome, in 
particular when considered alongside the mode of birth and choice of feeding method (i.e., 
breastfeeding or formula feeding). Beginning in utero, and during the first two years of an infant’s 
life, cells acquire an epigenetic memory of the neonatal exposome which can be influential across 
the entire lifespan. Parental lifestyle (e.g., malnutrition, alcohol intake, smoke, stress, exposure to 
xenobiotics and/or drugs) can modify both the maternal and paternal epigenome, leading to 
epigenetic inheritance in their offspring. This review aims to outline the origin of early life 
modulation of the epigenome, and to share this fundamental concept with all the health care 
professionals involved in the development and provision of care during childbirth in order to 
inform future parents and clinicians of the importance of the this process and the key role it plays 
in the programming of a child’s health. 
Keywords: nutri-epigenetics; gut microbiota; breastfeeding; birth care; best practice; parent 
education 
 
1. Introduction 
Nutri-epigenetics is the study of the role of dietary components in the modulation of the 
epigenome [1,2]. Food oxidation produces different metabolites involved in the modulation of 
chromatin structure and in the regulation of gene expression. For example, acetyl groups from 
Acetyl-CoA are used by histone acetyltransferases (HATs) to neutralize the charges at chromatin 
level, by decreasing the electrostatic interaction between the positive charge of aminoacidic residues 
at the histone tails and the negative charge of phosphate groups of the DNA [3]. The acetylation of 
specific amino acidic residues of the histone tail is associated with open chromatin, thus it can turn 
on gene expression. Whereas deacetylation leads to condensation of chromatin and gene silencing. A 
range of effects on the modulation of gene expression can be derived from histone methylation, which 
takes place in the addition to one or more methyl groups at the aminoacidic residues of histone tails 
[1]. The enzymes involved in histone methylation are the histone methyltransferases (HMTs) which 
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receive the methyl group from the S-adenosyl-methionine (SAM), the universal methyl donor, which 
is the final product of the one carbon cycle. In particular, the one carbon cycle combines the folic acid 
cycle with the methionine cycle to synthetize the SAM, which donates methyl groups to both DNA-
methyltransferases (DNMTs) and HMTs [4]. Indeed, methyl groups provided by SAM are also used 
for methylating DNA sequences. It is well established that methylation of DNA at the carbon 5 of 
cytosines in the CpG islands of the promoter region of genes regulates their expression according to 
the percentage of promoter methylation. An increase in promoter methylation is associated with a 
decrease in the gene expression [1,5] and consequently to downregulation of protein level. The impact 
of promoter methylation in the regulation of gene expression can be explained considering the 
interference due to the methyl groups which negatively affect interaction with proteins (e.g., 
transcription factors, RNA-polymerase) involved in promoter recognition which is necessary to start 
gene transcription [4]. DNA methylation is regulated by the activity of specific enzymes: DNA-
methyltransferase 1 (DNMT1), DNA-methyltransferase 3A (DNMT 3A) and DNA-methyltransferase 
3B (DNMT 3B). DNMT1 has the role of maintaining DNA methylation during cell replication and 
guarantees the inheritance of the methylome during DNA replication and the permanence of the 
specific characteristics of the cell, while DNMTs 3A and 3B can catalyze the de novo methylation 
which depends to the impact of environmental stimuli (e.g., food, stress, xenobiotics, etc.) [1–3]. To 
ensure normal activity of the one carbon pathway, folic acid, vitamin B2, B6 and B12 are required; 
these micronutrients must be included in the diet because they represent the substrates used by the 
enzymes involved in the one carbon cycle to produce the methyl groups that the enzymes DMNTs 
and HMTs use for the proper DNA and histone methylation [5]. 
Gut microbiota also play an important function in epigenome remodeling [1]. The metabolites 
produced by gut microbiota can actively modulate the epigenome of the host, thus affecting his/her 
health status. Richness is the total number of bacterial species in the gut microbiome, while diversity 
is the number of individual bacteria from each of the bacterial species present in an individual’s gut 
microbiome. This relevant because richness and diversity of gut microbiota are the two major 
determinants of the health status. Indeed, bacteria can metabolize all kinds of fibers contained in 
food, such as vegetables, fruits and whole grains, producing short-chain fatty acids (SCFAs) (e.g., 
butyrate, propionate and acetate) which actively modulate gene expression and the epigenome in the 
colonocytes [5]. In particular, the SCFAs mediate both anti-inflammatory and metabolic responses, 
thus leading to positive systemic effects on lipid and carbohydrate metabolism [6,7]. Butyrate is a 
SCFA that promotes anti-inflammatory responses by interacting with receptors in colonocytes (e.g., 
GPR109A), immune cells (e.g., GPR43, GPR41) and adipocytes (e.g., GPR41) [8]. It inhibits the release 
of proinflammatory cytokines (e.g., IL6, IL12) and promotes anti-inflammatory responses (i.e., IL10). 
In doing so butyrate contributes to the maintenance of cellular homeostasis in the gut. Studies from 
animal models and cell lines highlight that the anti-inflammatory properties of butyrate also depend 
on the downregulation of the transcription factor NF-kB which controls the gene expression of 
proinflammatory cytokines [9]. Butyrate also plays a central role in lipid and glucose metabolism. By 
interacting with GPR43 and GPR41 receptors, it increases glucagon-like peptide 1 and peptide YY, 
decreasing glucagon production in the pancreas and increasing glucose uptake in muscle and adipose 
tissues. Butyrate increases fatty acid oxidation in muscle and decreases lipolysis in white adipose 
tissue resulting in a change in the body composition. Finally, butyrate can be also transported to the 
liver where it is metabolized to produce ATP. To support these functions more effectively a diet rich 
in fiber is necessary to modulate a healthy response by gut microbiota across the life span. 
Considering the interplay between nutrition, gut microbiota and the epigenome, the first aim of 
this review is to describe the connections between early life nutrition (e.g., breastfeeding), childbirth 
(e.g., mode of delivery) and mode of care with gut microbiota modulation. Second, the role of 
maternal lifestyle in the programming of the infant’s health will be described, highlighting the impact 
of early life modulation of the epigenome. Finally, this review aims to share this fundamental 
information with all the health care professionals involved in maternity care, in order to promote the 
delivery of the best practices around birth. 
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2. Epigenetic Programming during the First 1000 Days of Life 
Epigenetics etymologically means “on top of” or “in addition to genetics” to highlight the fact 
that it modulates gene expression without any change in the nucleotide sequence. Epigenetics 
contributes to cell differentiation during the first 1000 days of life—a period that includes forty weeks 
of pregnancy plus the first two years of life. DNA methylation switches genes off in order to 
differentiate more than 250 cell types that characterize tissues and organs in our body. Cells acquire 
an epigenetic memory of the neonatal exposome which is maintained throughout life. 
Environmental cues (e.g., food, xenobiotics, stress, etc.) can regulate phenotypic diversity in the 
same genome and can influence the inheritance of epigenetic marks [10–14]. During this window of 
epigenetic plasticity, fetal growth, organ maturation and susceptibility to disease are all 
programmed. 
Therefore, if the environmental cues are unhealthy (e.g., poor methyl group donor diet, 
endocrine disruption, stress, etc.), unwanted changes in the epigenome can occur, and alterations of 
gene expression could be observed later in life (e.g., at adolescent or adult age) increasing the risk for 
multifactorial environmentally driven diseases [4,5]. 
In support of this theory, several studies have found that maternally induced epigenetic 
programming and malnutrition (e.g., low Vitamin B12, low protein intake, high fat diet, exposure to 
endocrine disruptors, etc.,) during pregnancy can modulate body mass index, glucose tolerance, 
cardiovascular disease risk in the infant. The extent to which epigenetic programming is affected is 
influenced by both gender and the period of exposure to environmental factors. Severe maternal 
famine (about 400–800 kcal/die) exposure during the first trimester of pregnancy has been associated 
with changes in the promoter methylation of several genes (e.g., IL10, INS-IGF2, GNASAS, LEP, 
ABCA1 and MEG3) [15–17]. Long-term effects include an increased risk of developing obesity in adult 
men [17] and a higher incidence of glucose intolerance in adult women [15–17]. Maternal adiposity 
and changes in the newborn DNA methylation have been observed in 19 cohorts within the PAGE 
consortium [18]. The consortium data found a correlation between promoter methylation at retinoid 
X receptor-α (RXRA) in umbilical cord blood and an increase of fat mass in 6- and 9-year-old children 
[19]. Correlations between maternal blood, cord blood metabolites (e.g., homocysteine, TMAO, 
5meTHF, Vitamin B12, choline, methionine, SAH, etc.) and DNA methylation have been observed 
highlighting the key role of maternal metabolites in the modulation of the offspring’s epigenome [20]. 
Stress in utero and during early postnatal life, as well as childhood maltreatment, influence the 
hypothalamic–pituitary–adrenal axis resulting in fetal exposure to excess glucocorticoids [21]. 
Perkeybile and colleagues [22] demonstrated that a low level of early care leads to de novo DNA 
methylation at regulatory sites in the oxytocin receptor gene in the brain and blood and to the 
downregulation of the oxytocin receptor’s expression in the brain of infants [23]. This evidence 
demonstrates that both diet and maternal care are directly involved in the programming of adult 
health and act via epigenetics. Indeed, studies on animals show that stress due to maternal separation 
has been associated with modifications in fear regulation (e.g., an increased risk of developing 
anxiety, a higher consumption of palatable food). Remarkably, male rat offspring were more 
vulnerable than females to the effects of neonatal stress on anxiety-like behavior, as well as on food 
consumption [24,25]. Stress due to early life exposure to food pesticides (even at low dosage) in 
animals can modify neuronal development, leading to progressive neurodegeneration in adulthood. 
Aberrant epigenetic marks and biomarkers of neuronal damage can be inherited in offspring when 
both parents and only the mother are exposed to a low dosage of pesticide (near to the DL50) during 
their brain development [10,26]. 
Paternally induced epigenetic programming has been observed [27]. Offspring from prenatally 
undernourished fathers (where the mother was appropriately nourished), were more obese than 
offspring where both parents were eating a normocaloric diet before conception [28]. Studies on 
offspring born from fathers with a high-fat-diet (HFD) show changes in pancreatic DNA methylation 
[29]. Paternal low protein intake leads to altered expression of enzymes involved in the cholesterol 
metabolism in the liver in the offspring [30]. Pre-diabetes in fathers increases the risk of diabetes in 
their offspring [31]. Paternal exposure to nicotine or cocaine prior to conception influences the 
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offspring’s drug resistance, affecting the expression of genes involved in the xenobiotic metabolism 
[32]. 
In summary, both epigenetic marks from mothers before and during pregnancy as well as those 
acquired from fathers can be inherited by the fetus. Malnutrition, alcohol, stress, smoking, xenobiotics 
and drugs can modify the epigenome of the future parents and the altered epigenetic marks 
potentially can be inherited by their offspring leading to epigenetic changes associated with the 
features of metabolic syndrome [27,33,34]. 
Moreover, further evidence derived from studies carried out on rodents demonstrates that small 
non-coding RNAs (sncRNAs) levels in sperm are influenced by the father’s life-style and 
environment. These sncRNAs contribute to the regulation of gene expression and endogenous 
mRNA transcription, and they play an important role in the post-fertilization zygote influencing 
early embryonic development [33]. Early postnatal stress has been associated with changes in 
sncRNAs profile in the sperm, and paternal high-fat diet can modify metabolic responses in the 
offspring also through spermatic sncRNAs [35]. 
Both intergenerational (i.e., subject directly exposed to the environmental stimuli) and 
transgenerational (i.e., subject was not directly exposed to the environmental insult) inheritance have 
been demonstrated in animal models [36]. Cardiac dysfunction induced by parental HFD persist for 
two subsequent generations in Drosophila, also when the offspring received a normal fat diet (NFD) 
[36]. A significant increase in whole-body H3K27me3 levels that persisted in the next NFD-fed 
generation has been observed, and the pharmacological inhibition of the H3K27 methyltransferase 
was able to block the intergenerational inheritance [37]. This study underlines another key aspect of 
epigenetics: its potential reversibility [38,39]. The plasticity of DNA methylation under different 
environmental conditions has been extensively evaluated in cell cultures, plants and animal models 
[38,39]. Human embryonic stem cells (hESCs) adapted to different culture conditions can have up- 
and downregulated genes that can reverse differently their DNA methylation profile [38]. 
The epigenetic impact of environmental cues and the epigenetic reversibility have their main 
plasticity during the first 1000 days of life: this is the “window of plasticity”, i.e., the period of life 
when the control of the future generations’ health can be properly addressed. 
3. Gut Microbiota at Birth 
It is yet to be established if any interaction with different bacteria via the placenta, umbilical cord 
or amniotic fluid actually occurs [40–42] and if it did what the consequences of such an interaction 
would mean for the health of the newborn. However, it has been established that is widely the 
composition of gut microbiota can be influenced by several factors such as genetics, ethnicity, food 
intake, environment, sex differences, gastrointestinal pH and oxygen/redox state [43,44]. Gestational 
age, mode of birth and breastfeeding can have an additional effect on gut microbiota composition in 
the first four years of life [45,46]. Preterm babies have been shown to have decreased diversity and 
lower concentration of Bacteroides and Bifidobacterium compared to infants born full term [47]. Their 
microbiota can be further reduced by antibiotic treatment and the environment of the intensive care 
unit [48]. Moreover, babies born by cesarean section (CS) also show a similar reduction in the 
diversity in their microbiota when compared to infants born vaginally [49]. 
Babies born by CS have more contact with the environmental microbiota (i.e., healthcare 
professionals) than with their mother’s microbiota (where exposure takes place in the vagina), 
resulting in a strong presence of epidermal Staphylococci. Dominguez-Bello et al., [50] identified that 
maternal vaginal bacteria (e.g., Lactobacillus, Prevotella or Sneathia spp.) were commonly found in 
infants born vaginally while maternal skin microbes (e.g., Staphylococcus, Corynebacterium and 
Propionibacterium spp.) were prevalent in infants born by CS. Shao et al., [51] observed in 596 full-
term babies that birth by CS is associated with maternal transmission of Bacteroides strains and 
opportunistic pathogens (e.g., Enterococcus, Enterobacter, Klebsiella species), and that a similar picture 
can be observed in babies born by vaginally from mothers treated with antibiotics as well as in infants 
who are formula fed. Microbial composition in babies born vaginally consisted of up to 68.3% of 
Bifidobacterium, Escherichia, Bacteroides and Parabacteroides species [51]. Wampach et al., [52] similarly 
Int. J. Mol. Sci. 2020, 21, 5032 5 of 17 
 
reported the profusion of Bacteroides and Parabacteroides in infants born vaginally, while an increase 
in the Staphylococcus was described following CS. Penders et al., [53] observed that in full-term infants 
born by CS, there is a 100-fold lower number of Bifidobacteria and Bacteroides fragilis when compared 
to those born vaginally. A 100-fold higher level of Clostridium difficile strains and increased level of 
Escherichia coli have been identified in the gut of babies delivered by CS than in those who were born 
vaginally and received exclusively breastfeeding [53]. A systematic analysis from Rutayisire et al., 
[54] highlights that CS is associated with a lower abundance and diversity of Actinobacteria and 
Bacteroidetes phyla and a higher abundance and diversity of the phylum Firmicute than in vaginally 
delivered infants. In addition, colonization of Bifidobacterium and Bacteroides genera, are present more 
frequently in vaginally derived infants when compared to babies delivered by CS, who in turn are 
preferentially colonized by Clostridium [54]. Moreover, investigation on gut microbiota by Liu et al., 
[55] on Chinese infants shows that vaginally delivered newborns harbor more Acinetobacter spp., 
Bifidobacterium spp. and Staphylococcus spp., while infants born by CS predominantly have Citrobacter 
spp., E. coli and Clostridium difficile strains. Shi et al. [56] observed additional differences in a Chinese 
cohort of infants, with an abundance in the Propionibacterium species in vaginally delivered babies, 
while in infants delivered by CS, there was a high presence of Bacillus licheniformis. 
Gut microbiota are healthier and more diverse in babies born vaginally when compared with 
infants born by CS. In addition, babies born vaginally also demonstrate an increased richness and 
diversity in microbiota which are associated with a healthy phenotype. The presence of different 
strains of bacteria in the gut can be modulated by food intake and postnatal factors such as maternal 
diet, breast feeding, formula-feeding and weaning [43]. Breastfeeding increases the number of 
Bifidobacterium in the infant’s gut when compared to those who are formula-fed [43]. The crosstalk 
between host cell and gut microbiota has been widely demonstrated; Teng et al., [57] showed that 
ginger exosomes-like nanoparticles can modulate gut microbiota composition due to RNAs 
contained in the plant. In mice, an improvement of intestinal barrier function has been observed 
following the administration of ginger. The ginger exosomes-like nanoparticles contain miRNA that 
are used by gut Lactobacillaceae, inducing the production of the protective IL-22 and enhancing gut 
barrier. Animal food (e.g., meat, egg, cheese) has been associated with a decrease of Firmicutes 
(Roseburia, Eubacterium rectale, Ruminococcus bromii) and an increase of Enterobacteriaceae (Shigella and 
Escherichia), while a high fiber diet promotes an increase in Bacteroidetes (e.g., Prevotella, Xylanibacter) 
and depletion of Firmicutes [58]. Polyphenols contained in fruit and vegetables promote the growth 
of beneficial pool of Bifidobacterium, Lactobacillus, Akkermansia and Faecalibacterium sp. and decrease 
in pathogenic organisms (such as Helicobacter pylori, Staphylococcus sp.) [59]. Vitamin C impact 
positively the gut microbiota microenvironment, increasing Lactobacillus and Bifidobacterium and 
decreasing E. coli [60]. Pre- and postnatal Vitamin D3 exposure modulates the profusion of bacterial 
taxa in the infant microbial gut population [61]. Vitamin D supplementation has been associated with 
beneficial bacterial genera (e.g., Subdoligranulum, Ruminiclostridium, Intestinimonas, 
Pseudoflavonifractor, Paenibacillus, Marvinbryantia) which have been associated with an 
antihypertensive function in later life [62]. Vitamins A and E show a positive influence on beneficial 
microbes, such as Bifidobacteria, Akkermansia and Lactobacilli) [59]. This evidence supports the 
existence of a direct link between diet and microbiome composition, which, as previously described, 
is a strong determinant of health. 
The composition of gut microbiota can influence neuronal development and homeostasis in the 
infants [63,64]. The effect of stress on the gut–brain axis has been associated with changes in gut 
microbiota, alterations in brain derived neurotropic factor, behavioral changes, and it can even lead 
to anxiety and depression [63]. This evidence highlights that the composition of microbiota could 
represent a new strategy for the prevention of mental illness [65]. Studies on stressed adolescent rats 
treated with a preventive diet containing ω-3 polyunsaturated fatty acids (e.g., eicosapentaenoic acid, 
docosahexaenoic acid, docosapentaenoic acid) and vitamin A, did not show any decline in brain-
derived neurotrophic factor expression in the hippocampus, and not even any change in the 
composition of microbiota, that was previously detected in the stressed rats [66]. 
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Administering antibiotics has the potential to selectively alter the composition of gut microbes. 
The effect on both mother’s and child’s health of administering antibiotics during pregnancy or 
around the time of birth has not been completely elucidated. Several studies have been carried out to 
investigate the potential adverse effects of using antibiotics prenatally, during pregnancy or 
neonatally on the baby’s gut microbiome and the development of the infant immune system—
possibly leading to childhood atopy, asthma, allergy and obesity [67,68]. 
In contrast, studies in which mice had their microflora remodeled by broad-spectrum antibiotics 
show that this treatment induces changes in regulatory T-cells conferring protection against 
experimental autoimmune encephalomyelitis (EAE), in animal model of CNS demyelinating 
disorders [69]. This tolerance was associated with reduced circulating proinflammatory cytokines 
and increased levels of IL-10 and IL-13, which are potent anti-inflammatory cytokines [70]. Antibiotic 
treatment also proved to be beneficial to children with regressive onset autism in the short term 
[71].Treatment for hepatic encephalopathy with rifaximin showed improved cognitive abilities 
posttreatment together with reduced endotoxemia and improved white matter integrity in patients 
[72]. 
Current research regarding the effect of antibiotic administration during pregnancy and birth 
gives insufficient attention to the confounding variables (such as type of antibiotic, dosing, mode of 
administration, etc.). In most studies, there is a lack of control for the timing of the use of antibiotics, 
the type and class of antibiotic and whether it is broad spectrum or not, the indication and the number 
of antibiotic courses administered [73,74]. 
In conclusion, gut microbiota composition at birth can be modulated by vaginal or CS birth, 
antibiotic administration and maternal diet. Since the presence of different strains of bacteria in the 
gut are associated with the production of metabolites able to positively modulate immune and 
metabolic responses in the infants, particular attention should be given by clinicians and healthcare 
professionals to promote gut microbiota diversity, maternal diet and mode of birth in order to 
maximize outcomes for mother and infant. 
4. Mode of Birth 
Significant progress in terms of surgical skills, blood transfusion, the development of antibiotics, 
etc., has reduced the mortality associated with CS and has reduced the risk to both mothers and 
neonates. As CS became a safer procedure, CS rates have increased worldwide (without 
commensurate improvements in perinatal mortality). For example, in Italy, CS rates in the 1980s were 
approximately 11% and had peaked to 38% by 2018. Similarly, in Australia, rates have increased from 
11.8% to 47.4% across 81 hospitals with rates of 82.1% among 61,894 maternities with one previous 
CS [75]. This highlights the extent to which the first birth by CS of a repeat CS in subsequent 
pregnancies. The indications for CS have also changed over time as maternal request for CS in the 
absence of any medical indication (Cesarean Delivery on Maternal Request-CDMR) is becoming a 
clinically important factor. The extent to which maternal request for CS was influencing CS rates 
internationally led the American College of Obstetricians and Gynecologists (ACOG) to disseminate 
specific recommendations for obstetricians: ”in the absence of other indications for early delivery, cesarean 
delivery on maternal request should not be performed before a gestational age of 39 weeks; and, given the high 
repeat cesarean delivery rate, patients should be informed that the risks of placenta previa, placenta accreta 
spectrum, and gravid hysterectomy increase with each subsequent cesarean delivery” [76]. 
An inappropriate use of surgery in childbirth has led not only to an increase in CS births, but 
also to a corresponding fall in vaginal birth after cesarean (VBAC) rates without any improvement in 
maternal or neonatal mortality [77]. Moreover, concerns are growing as to the short and long term 
adverse effects of CS [78], both for elective and emergency indications [79]. With respect to the mother 
adverse effects of CS include complications of surgery and anesthesia, the risk of hemorrhage 
requiring a blood transfusion, trauma due to intraoperative surgical injury, infection, pelvic 
adhesions, risk of placenta accreta syndrome, uterine rupture, and peri-partum hysterectomy. 
Adverse effects on the neonate include transient tachypnoea of the newborn, reduced breastfeeding 
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rates and the consequent long-term risk associated with same, an increased risk of still birth and 
preterm birth in subsequent pregnancies [80]. 
Performing a VBAC is difficult as it remains prohibited in some countries contrary to the 
evidence and guidance produced by the National Institute of Health (NIH) and the American College 
of Obstetricians and Gynecologists (ACOG) who continue to recommend a “Trial of Labor after 
Cesarean” (TOLAC) for women who had one previous CS [81]. The safety of offering a VBAC to 
women following one previous CS has been demonstrated in a pan-European trial [81,82]. However, 
in practice, the trend of increasing CS that is occurring worldwide is difficult to reverse. Therefore, 
having a VBAC after a first CS in low risk women is highly encouraged, due to the potential beneficial 
epigenetic effects for the infant born vaginally. In contrast, elective/pre-labor CS is associated with 
altered short-term immune responses such as reduced expression of inflammatory markers in the 
newborn infant [80,83–91]. Infants born by elective CS also face a greater risk of developing immune 
diseases such as asthma, allergies, type 1 diabetes and coeliac disease [80,83–91]. 
Mode of birth is not only an obstetric issue as giving birth by CS affects the epigenetic state of 
different neonatal systems. In the case of CS birth, many babies are born before or at 39 weeks 
gestation, most mothers receive intraoperative antibiotics which has been shown to affect microbiota 
colonization of the infant’s gut which have been linked with a higher risk of specific diseases such as 
asthma, coeliac disease, obesity [92]. This is concerning when considered in contrast to the gut 
microbiota variation that exists in infants born vaginally at full term who are also breast fed. 
Mode of birth does affect the epigenetic state of hematopoietic stem cells [93]. This may have 
important implications for health and disease in later life [79], and in turn may have an impact on 
short- and long-term health outcomes such as neural and behavioral development. 
Of note, it has been shown that infants who were born by CS may experience cognitive and 
motor development delay at nine months of age [81]. Another study suggests that these infants show 
an increased risk of approximately 20% of having a diagnosis of autism spectrum disorder (ASD) 
[94]. A link seems to exist between CS and an increased risk ASD and attention-deficit/hyperactivity 
disorder (ADHD) not observed in infants born vaginally. Thus, the importance of mode of birth as a 
key factor in terms microbial and brain development warrants further investigation if we are to 
maximize all opportunities to have a positive impact on health outcomes from birth and across the 
lifespan [95]. Although this study has been supported by a recent meta-analysis [96] further studies 
are needed as the association between mode of birth and impairment of neuronal development has 
not been detected when using sibling controls, suggesting that this association is likely confounded 
by genetic and/or environmental factors. 
5. Breastfeeding Versus Formula Feeding 
Human breast milk is an optimal food for infants, not only because of its constituents, but also 
because of its dynamic nature, which changes to meet infant requirements as he/she grows. The 
variety of nutrients and bioactive molecules contained in breastmilk contribute positively to healthy 
growth and neurodevelopment. Several studies have shown that maternal nutritional status has an 
impact on milk composition, which in turn affects infant development [97]. 
Epidemiological studies on the long-term effect of breastfeeding on health have shown that 
breastfeeding in the first six months of life positively impacts on the infant’s anti-inflammatory 
responses, body mass index and blood pressure [98–100]. Furthermore, a decrease in the plasma level 
of IL6 has been measured in mothers who exclusively breastfeed their babies for more than six 
months [101]. Data from longitudinal studies report that exclusive breastfeeding for 3–12 months 
decreases from 20% to 28% the level of C reactive protein (CRP) in adulthood (28–32-year-olds) [98]. 
Observational studies have shown that a high protein intake associated with formula feeding is 
connected to rapid weight gain and obesity later in life in [99]. A multicenter European study on 1138 
healthy infants showed a decrease in weight (e.g., length for age, weight for age, BMI) in those who 
were breastfed during their first year of life when compared with infants who were formula-fed. A 
positive reduction in body weight was observed when cow’s milk-based infant formula was 
decreased from high (2.9 and 4.4 g protein/100 kcal, respectively) to low protein content (1.77 and 2.2 
Int. J. Mol. Sci. 2020, 21, 5032 8 of 17 
 
g protein/100 kcal) [102,103]. The composition of breast milk is highly dynamic, and it varies across 
time. Leptin, ghrelin, adiponectin, insulin and more than 275 metabolites have been detected in breast 
milk [92,93], and changes in its composition from the 1st to the 6th month postpartum responds to 
infant requirements, particularly for central nervous system development. Long chain omega-3 fatty 
acid docosahexanoic acid (DHA), lutein, carotenoids and tocopherol are components of breast milk 
that have a key role for brain and retina development [104]. In a longitudinal study on infant rhesus 
macaques, Liu et al. [105] demonstrated structural brain differences that were capable of influencing 
brain development between breastfed and formula-fed animals. The presence of carotenoids and 
Vitamin E in formula milk was not able to mimic the efficacy of breast milk. 
Longitudinal studies on children have shown that breastfed babies have healthier dietary 
patterns later in life, compared to children who were formula-fed [106,107]. The intake of vegetables 
can be modulated by the mother during pregnancy and lactation, as the nutrients from these can pass 
to the fetus/infant through the placenta and breastmilk [106,107]. Breastfeeding can also impact 
pubertal maturation [108]. A prospective study in 1237 girls, showed a later onset of breast 
development in girls who were breastfed compared to formula fed ones [108]. 
Exclusive breastfeeding (EBF) plays an important role in establishing the neonatal gut 
microbiota, leading to short and long-term benefits across different populations [109]. Although 
previous studies on the differences in gut microbiota between EBF and non-EBF infants have 
provided conflicting results, a meta-analysis has shown that, in the first six months of life, gut 
bacterial diversity, relative abundance of Bacteroidetes and Firmicutes and predicted microbial 
pathways related to carbohydrate metabolism are consistently lower in EBF infants [110]. In addition, 
infants display higher relative abundance of pathways related to vitamin and lipid metabolism and 
detoxification. In addition, there is reduced diarrhea-related gut microbiota dysbiosis associated with 
longer duration of EBF [110]. 
While EBF has been found to be beneficial for the composition of the gut microbial colonization 
in term infants, there is limited evidence about the influence of type of feeding on the gut microbiome 
of preterm infants [111]. Studies show that preterm infants with a diet consisting of at least 70% 
maternal milk have an increased gut microbial diversity in early life, with the highest abundance of 
Bacillales, Lactobacillales and Clostridiales when compared to other infants in different feeding groups. 
In preterm infants there is a high risk of dysbiosis of the gut microbiome as prematurity of the gut 
microbiota together with the preterm breast milk composition and the environment of the neonatal 
intensive care unit, pose a significant challenge in neonatal nutritional care [111]. 
Although the benefits of breastfeeding are widely accepted, challenges to find optimal ways to 
support mothers to continue to BF following initiation remain. Begley at al. [112] found that the 
timing of breastfeeding support was particularly crucial in the immediate postnatal period. In a 
model of care where midwives are perceived to be inaccessible, i.e., busy with other clinical activities, 
then this can lead to a situation where women are reluctant to seek help and support with 
breastfeeding. This has been associated with a negative impact on the continuation of breastfeeding 
on discharge, in particular, in a setting where community support for breastfeeding is almost non-
existent. Some data are emerging that a midwifery-led continuity model of care may have a positive 
effect on the duration of exclusive breastfeeding at least up to 16 weeks postpartum. The midwifery 
led model in this trial included providing continuity of breastfeeding information and support in 
pregnancy, during birth, in hospital and following discharge in the form of home visits [113]. 
McFadden at al. previously concluded that consistent breastfeeding support tailored to women’s 
needs seems to increase the duration of exclusive breastfeeding [114]. Therefore, it seems that when 
support for breastfeeding is built in to the model of care, women can be identified from groups with 
particularly low breastfeeding rates for additional targeted support in order to increase the numbers 
of infants in these groups who would benefit immensely from the benefits of receiving breast milk. 
In summary, breastfeeding has a key role in the modulation of gut microbial composition and 
as a consequence has a positive impact on health in the long-term. The duration of breastfeeding, 
whether its exclusive or not and maternal nutritional status while breastfeeding can have a significant 
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impact on the infant’s health. Midwifery care in particular when targeted towards women who 
require additional support may have benefits to mothers and babies across the lifespan (Table 1). 
Table 1. Table summarizing the main findings of the positive impact of breastfeeding. 
Parameter Breastfeeding Reference 
Nutrients >richness in bioactive compounds [85,93–96] 
Duration of breastfeeding 1 
>anti-inflammatory  
Response 
[86–89] 
Effects in the adulthood 
<[CRP] 
<[IL6] 
healthier dietary patterns 
[87,97–99] 
Protein intake 
Adequate intake:  
<body weight  
<BMI 
[90–92] 
Brain health Structural differences promoting brain development [96] 
Gut health 
>microbiome diversity 2  
>microbiome abundance 2  
<episodes of diarrhea 2 
[100–103] 
Midwifery promotion of breastfeeding >maternal compliance in breastfeeding [104,105] 
1 > 6 months; 2 in both in term and preterm infants. 
6. Best Practice, Culture and Education 
Birth is the outcome of a complex evolutionary process in which an intricate neurohormonal 
system mediated by oxytocin [115] plays a crucial role. 
To date, our understanding of the role of mode of birth (e.g., vaginal birth vs. CS) is limited in 
terms of knowing if vaginal birth or CS can actually result in negative physiological consequences 
for infants, either in the short or in the long-term or both. It has been established that the normal 
process of labor, which often takes many hours, exposes the infant to many mechanical, hormonal 
and oxidative stresses potentially influencing physiology and life-long health. The three main 
mechanisms proposed to explain why mode of delivery, spontaneous, induced and/or augmented 
vaginal delivery versus CS, may affect neonatal development are: (1) exposure to varying levels of 
physical stress and stress hormone surges during birth; (2) differences in microbial colonization of 
the infant intestinal tract between vaginal birth and CS; and (3) epigenetic modifications of gene 
expression [4,116]. However, it is yet to be established if epigenetics can be also be modulated by a 
range of routine practices such as laboring lying down, being confined to bed with reduced mobility 
and continuous electronic fetal monitoring, in low risk mothers should be informed about the positive 
and negative factors able to impact the infant’s epigenome. 
Birth in hospital with a concurrent increase in the medicalization of the birth process has resulted 
in an overuse of intrapartum interventions and a global rise in CS as “mode of birth” [117]. Therefore, 
place of birth may be a factor that is associated with maternal wellbeing and birth outcomes [118]. 
Healthy women who have the opportunity to birth in settings/facilities that offer sufficient space to 
stand/move around, have access to birth companions and the support of a midwife on a one-to-one 
basis, are associated with improved outcomes and fewer interventions [119]. 
However, further research is required to establish if a link exists between maternal and infant 
epigenetic outcomes and the level of intervention/interference in the childbirth process [120,121], 
including mode of delivery [116]. Therefore, further investigation of the biologic/physiological 
processes in healthy childbearing women and fetus/newborn who have undergone unnecessary 
maternity care interventions is required [122] to offer new insights from an epigenetic perspective. 
7. Conclusions 
The study of nutri–epigenetic processes highlights important potential changes in the 
epigenome related to mode of birth, maternal lifestyle, method of infant feeding, etc. that can develop 
our understanding of how adult health is programmed during the first 1000 days of life. The parental 
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epigenome can be modified across the lifespan and the epigenetic marks of events that occur in utero 
can be inherited by progenies. Therefore, clinicians and healthcare professionals, who are offering 
care to families during pregnancy and childbirth should take the opportunity to inform parents of 
the long-term effects of an unhealthy diet and the benefits of breastfeeding across the lifespan. The 
positive impact of breastfeeding on gut microbiota differentiation and control of proinflammatory 
biomarkers later in life for the child and mother should be emphasized in order that women can make 
an informed choice for their own health and that of their newborn. Therefore, the importance of 
epigenetic research as a way of understanding the intergenerational impact of birth practices on the 
programming of the infant’s epigenome should not be underestimated. 
Table 2 summarizes the highlights of this review. 
Table 2. Table summarizing the main findings of this review. 
Highlights 
The epigenetic impact of environmental cues and the epigenetic reversibility have their main plasticity 
during the first 1000 days of life: the “window of plasticity” 
Environmental factors can modify the epigenome of the future parents 
The altered epigenetic marks from the parents potentially can be inherited by their upcoming offspring 
Gut microbiota composition at birth can be modulated by vaginal delivery or cesarian section 
Breastfeeding has a key role in the modulation of gut microbial composition as well as in the long-term 
impact on health 
The diversity of gut microbiota can guarantee the production of metabolites able to positively modulate 
immune and metabolic responses in the infants 
Clinicians and healthcare professionals, who are in close contact with the parents during pregnancy and 
childbirth, should take the opportunity to inform parents on the long-term effects of unhealthy diets 
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HATs histone acetyltransferases 
DNMT1 DNA-methyltransferase 1 
HMTs histone methyltransferases 
SCFAs short-chain fatty acids 
RXRA retinoid X receptor-α 
HFD high-fat-diet 
sncRNAs non-coding RNAs 
NFD normal fat diet 
hESCs human embryonic stem cells 
EAE experimental autoimmune encephalomyelitis 
CS cesarean section 
VBAC vaginal birth after cesarean 
ACOG American College of Obstetricians and Gynecologists 
TOLAC trial of labor after cesarean 
ERCS elective repeated cesarean section 
ASD autism spectrum disorder 
ADHD attention-deficit/hyperactivity disorder 
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CRP C reactive protein 
DHA acid docosahexanoic acid 
EBF exclusive breastfeeding 
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